Mutations in PURA cause profound neonatal hypotonia, seizures, and encephalopathy in 5q31.3 microdeletion syndrome
- PMID: 25439098
- PMCID: PMC4225583
- DOI: 10.1016/j.ajhg.2014.09.014
Mutations in PURA cause profound neonatal hypotonia, seizures, and encephalopathy in 5q31.3 microdeletion syndrome
Abstract
5q31.3 microdeletion syndrome is characterized by neonatal hypotonia, encephalopathy with or without epilepsy, and severe developmental delay, and the minimal critical deletion interval harbors three genes. We describe 11 individuals with clinical features of 5q31.3 microdeletion syndrome and de novo mutations in PURA, encoding transcriptional activator protein Pur-α, within the critical region. These data implicate causative PURA mutations responsible for the severe neurological phenotypes observed in this syndrome.
Copyright © 2014 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures

Similar articles
-
A 25 Mainland Chinese cohort of patients with PURA-related neurodevelopmental disorders: clinical delineation and genotype-phenotype correlations.Eur J Hum Genet. 2023 Jan;31(1):112-121. doi: 10.1038/s41431-022-01217-4. Epub 2022 Nov 14. Eur J Hum Genet. 2023. PMID: 36376392 Free PMC article.
-
Expanding the clinical phenotype and genetic spectrum of PURA-related neurodevelopmental disorders.Brain Dev. 2021 Oct;43(9):912-918. doi: 10.1016/j.braindev.2021.05.009. Epub 2021 Jun 8. Brain Dev. 2021. PMID: 34116881
-
Patient with a novel purine-rich element binding protein A mutation.Congenit Anom (Kyoto). 2017 Nov;57(6):201-204. doi: 10.1111/cga.12214. Epub 2017 Mar 24. Congenit Anom (Kyoto). 2017. PMID: 28164378
-
Differences in manifestations of epilepsy and developmental delay in PURA syndrome and 5q31 microdeletions.Clin Genet. 2024 Oct;106(4):386-393. doi: 10.1111/cge.14581. Epub 2024 Jun 24. Clin Genet. 2024. PMID: 38923490 Review.
-
PURA syndrome: clinical delineation and genotype-phenotype study in 32 individuals with review of published literature.J Med Genet. 2018 Feb;55(2):104-113. doi: 10.1136/jmedgenet-2017-104946. Epub 2017 Nov 2. J Med Genet. 2018. PMID: 29097605 Free PMC article. Review.
Cited by
-
The Molecular Function of PURA and Its Implications in Neurological Diseases.Front Genet. 2021 Mar 11;12:638217. doi: 10.3389/fgene.2021.638217. eCollection 2021. Front Genet. 2021. PMID: 33777106 Free PMC article. Review.
-
YAP and TAZ Regulate Cc2d1b and Purβ in Schwann Cells.Front Mol Neurosci. 2019 Jul 17;12:177. doi: 10.3389/fnmol.2019.00177. eCollection 2019. Front Mol Neurosci. 2019. PMID: 31379499 Free PMC article.
-
A novel de novo mutation in the PURA gene associated with a new clinical finding: large brainstem.J Genet. 2020;99:7. J Genet. 2020. PMID: 32089526
-
Recent developments in genetic/genomic medicine.Clin Sci (Lond). 2019 Mar 5;133(5):697-708. doi: 10.1042/CS20180436. Print 2019 Mar 15. Clin Sci (Lond). 2019. PMID: 30837331 Free PMC article. Review.
-
De novo mutations in PURA are associated with hypotonia and developmental delay.Cold Spring Harb Mol Case Stud. 2015 Oct;1(1):a000356. doi: 10.1101/mcs.a000356. Cold Spring Harb Mol Case Stud. 2015. PMID: 27148565 Free PMC article.
References
-
- Shimojima K., Isidor B., Le Caignec C., Kondo A., Sakata S., Ohno K., Yamamoto T. A new microdeletion syndrome of 5q31.3 characterized by severe developmental delays, distinctive facial features, and delayed myelination. Am. J. Med. Genet. A. 2011;155A:732–736. - PubMed
-
- Hosoki K., Ohta T., Natsume J., Imai S., Okumura A., Matsui T., Harada N., Bacino C.A., Scaglia F., Jones J.Y. Clinical phenotype and candidate genes for the 5q31.3 microdeletion syndrome. Am. J. Med. Genet. A. 2012;158A:1891–1896. - PubMed
-
- Brown N., Burgess T., Forbes R., McGillivray G., Kornberg A., Mandelstam S., Stark Z. 5q31.3 Microdeletion syndrome: clinical and molecular characterization of two further cases. Am. J. Med. Genet. A. 2013;161A:2604–2608. - PubMed
-
- Rosenfeld J.A., Drautz J.M., Clericuzio C.L., Cushing T., Raskin S., Martin J., Tervo R.C., Pitarque J.A., Nowak D.M., Karolak J.A. Deletions and duplications of developmental pathway genes in 5q31 contribute to abnormal phenotypes. Am. J. Med. Genet. A. 2011;155A:1906–1916. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases